Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.29
0.0551.7%
Ult. Agg.: Oct 30, 1:45 PM
Market sentiment signals for SAB Biotherapeutics (SABS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
14 analysts
Options Flow (P/C)
0.00
More calls — Bullish
Avg Consensus PT
$11
+230.6%
Highest Price Target
$16
+387.1%
Lowest Price Target
$6
+82.6%
Short Interest
5.5%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | Barclays | Eliana Merle— | +295.7% | $13 | Initiate | Overweight |
| Jun 17, 2026 | Chardan Capital | Keay Nakae— | +387.1% | $14 → $16 | Maintained | Buy |
